Document is current
Any future updates will be listed below
-
Authors
Schweickart, Annalise https://orcid.org/0000-0001-9691-3741
Chetnik, Kelsey
Batra, Richa https://orcid.org/0000-0003-3708-0086
Kaddurah-Daouk, Rima https://orcid.org/0000-0003-1858-5732
Suhre, Karsten
Halama, Anna https://orcid.org/0000-0003-4910-6255
Krumsiek, Jan https://orcid.org/0000-0003-4734-3791
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U19AG063744)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG069901-01)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 13 August 2024
First Online: 6 September 2024
Competing interests
: The authors declare the following competing interests: J.K. holds equity in Chymia LLC, owns intellectual property in PsyProtix, serves as an advisor for celeste, and is a co-founder of iollo. R.K-D. in an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix.
